Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
9,527,471
-
Share change
-
+9,527,471
-
Total reported value
-
$137,886,708
-
Price per share
-
$14.63
-
Number of holders
-
50
-
Value change
-
+$137,886,782
-
Number of buys
-
50
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2018
As of 31 Mar 2018,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,527,471 shares.
The largest 10 holders included
Polaris Venture Management Co. V, L.L.C., DISCOVERY CAPITAL MANAGEMENT, LLC / CT, FMR LLC, JENNISON ASSOCIATES LLC, Voya Investment Management LLC, FEDERATED INVESTORS INC /PA/, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Empyrean Capital Partners, LP, and VANGUARD GROUP INC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.